06.02.2015 17:35:27
|
Actelion to discuss full year 2014 financial results
Actelion Pharmaceuticals Ltd / Actelion to discuss full year 2014 financial results . Processed and transmitted by Nasdaq OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.
Dear member of the investment community
Actelion Ltd will announce its 2014 full year financial results on Monday, 16 February 2015, at 07.00 hrs CET / 06.00 hrs GMT / 01.00 a.m. ET. An investor conference call & webcast will be held at 14.00 hrs, CET.
Date/Time:
16 February 2015 | 14.00 hrs - 14.45 hrs | Basel (CET) |
13.00 hrs - 13.45 hrs | UK (GMT) | |
08.00 a.m. - 08.45 a.m. | US (ET) |
Conference Call Connect #:
Dial-in participants should start calling the number below 10-15 minutes before the conference is due to start.
Dial: | Europe: | +41 (0)44 580 00 74 | |||
UK: | +44 (0) 203 043 24 39 | ||||
US: | +1 866 907 59 25 |
Participant's mode:
Listen-Only with possibility to open individual lines during Q&A session.
Participants will be asked for their Name and Company.
Webcast Access:
Webcast participants should visit the Actelion website http://www.actelion.com 10-15 minutes before the conference is due to start.
Participant's mode:
Listen-Only
Webcast Replay:
The archived Investor Webcast will be available for replay through http://www.actelion.com/ approximately 60 minutes after the call has ended.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Actelion Pharmaceuticals Ltd via Globenewswire
--- End of Message ---
Actelion Pharmaceuticals Ltd
Gewerbestrasse 16 Allschwil Switzerland
ISIN: CH0010532478;
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Actelion Ltd.mehr Nachrichten
Keine Nachrichten verfügbar. |